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Abstract
Background: Given the theoretical proposal that bovine spongiform encephalopathy (BSE) could have originated
from sheep scrapie, this study investigated the pathogenicity for cattle, by intracerebral (i.c.) inoculation, of two
pools of scrapie agents sourced in Great Britain before and during the BSE epidemic.
Two groups of ten cattle were each inoculated with pools of brain material from sheep scrapie cases collected
prior to 1975 and after 1990. Control groups comprised five cattle inoculated with sheep brain free from scrapie,
five cattle inoculated with saline, and for comparison with BSE, naturally infected cattle and cattle i.c. inoculated
with BSE brainstem homogenate from a parallel study. Phenotypic characterisation of the disease forms
transmitted to cattle was conducted by morphological, immunohistochemical, biochemical and biological
methods.
Results: Disease occurred in 16 cattle, nine inoculated with the pre-1975 inoculum and seven inoculated with
the post-1990 inoculum, with four cattle still alive at 83 months post challenge (as at June 2006). The different
inocula produced predominantly two different disease phenotypes as determined by histopathological,
immunohistochemical and Western immunoblotting methods and biological characterisation on transmission to
mice, neither of which was identical to BSE. Whilst the disease presentation was uniform in all scrapie-affected
cattle of the pre-1975 group, the post-1990 inoculum produced a more variable disease, with two animals sharing
immunohistochemical and molecular profile characteristics with animals in the pre-1975 group.
Conclusion: The study has demonstrated that cattle inoculated with different pooled scrapie sources can
develop different prion disease phenotypes, which were not consistent with the phenotype of BSE of cattle and
whose isolates did not have the strain typing characteristics of the BSE agent on transmission to mice.
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Background
Bovine spongiform encephalopathy (BSE) is a progressive
and fatal neurological disease of cattle, which was first dis-
covered in Great Britain (GB) in 1986 [1]. Epidemiologi-
cal studies support the view that the cattle population was
exposed to a scrapie-like agent through the feeding of
meat and bone meal after changes in rendering practices.
Recycling of the agent increased exposure of cattle to a
scrapie-like agent, resulting in the large epidemic of BSE.
It is hypothesised that the cattle-adapted BSE agent origi-
nated either from sheep scrapie, the transmission result-
ing directly in clinical disease, or from cattle with a
scrapie-like disease that was present endemically in cattle
at a low level prior to the epidemic [2].
Strain typing of transmissible spongiform encephalopa-
thy (TSE) isolates in mice from cattle, exotic ruminant
species and domestic cats, also of isolates of experimental
BSE in sheep, goats and pigs [3,4] indicate the unique sin-
gularity of the BSE agent in GB, its apparent dissimilarity
to isolates of natural scrapie of sheep, and its stability on
natural or experimental single passage in the several spe-
cies. Neuropathological studies profiling vacuolar
changes in BSE [5,6] have also provided evidence of the
single phenotype of BSE in GB and allow comparisons to
be made with possible other TSE phenotypes in cattle
caused by different agent strains.
As well as vacuolation within the brain, all TSEs are char-
acterised by the accumulation of abnormal prion protein
(PrPSc) in the central nervous system. Synthetic forms of
this protein may transmit disease phenotypes without uti-
lising a nucleic acid genome by acting as a template, bind-
ing, and changing the conformation of the normal
cellular prion protein (PrPC) to replicates of PrPSc [7].
Although both have the same amino-acid sequence, PrPSc,
unlike PrPC, is relatively resistant to proteolysis and insol-
uble in mild detergents. These different physico-chemical
properties between normal and disease-associated PrP can
be used to study the pathology and biochemistry of the
disease group by the detection of PrPSc by immunohisto-
chemistry (IHC), and the protease-resistant core of PrPSc
(PrPres) by Western immunoblotting (WB). WB methods
have recently been used to characterise different TSE
strains, based on molecular masses and ratio of the result-
ant glycoforms after digestion with proteinase K [8]. These
have shown similarities in different BSE isolates [8-10],
which further suggests that BSE is caused by a single strain.
Experimental studies conducted in the USA have demon-
strated that natural ovine scrapie can be transmitted to
cattle after parenteral inoculation resulting in a prion dis-
ease with clinical and pathological findings unlike those
of BSE [11,12] and that, on passage in cattle, the disease
phenotype does not change substantially [13,14]. The
results cannot be extrapolated to the situation in GB
because of the potential difference between scrapie strains
in the USA and in GB. To provide some understanding of
the strain (or strains) of scrapie in sheep in GB, their pos-
sible changed properties on passage in cattle and the
dynamics of a selection process which might result in BSE,
a large series of studies were initiated in the United King-
dom in the mid 1990s. One of these, the present study,
investigated the pathogenicity for cattle, by intracerebral
(i.c.) inoculation, of two pools of scrapie agents sourced
in GB before and during the BSE epidemic. The transmit-
ted disease forms in recipient cattle were characterised by
clinical, pathological, biochemical and biological strain
typing approaches and compared with i.c. induced and
naturally infected cases of BSE in cattle. This study design
could, within the limitations of the source materials,
potentially identify an endemic form of scrapie patho-
genic for cattle and/or the occurrence of the BSE agent in
the GB sheep population.
Results
At the time of writing (June 2006), nine out of ten cattle
from the pre-1975 group and seven out of ten cattle from
the post-1990 group have succumbed to experimental
challenge. The remaining live animals are currently at 83
months post inoculation (mpi, this is based on the calen-
dar month and always rounded down).
Clinical assessments
Two clinical presentations could be distinguished: a dull
or somnolent form, exhibited by all nine steers in the pre-
1975 group and by five steers in the post-1990 group, and
a nervous form, exhibited by two animals (PG 920/01 and
PG512/02) in the post-1990 group (Table 1). All affected
steers became ataxic resulting in difficulty in rising. Steers
presenting with the dull form stood motionless in the pen
with the head lowered or resting against objects, such as
hurdles or a wall, when undisturbed and did not over-
react to external stimuli. However, this was not the case in
the two steers presenting with the nervous form; these ani-
mals displayed over-reactivity to external stimuli and
increased nervousness as the disease progressed. In addi-
tion, four animals in the pre-1975 group displayed signs
suggestive of generalised seizures. These were found in lat-
eral recumbency with limb "paddling", but regained their
footing with assistance, although they appeared to have a
slightly disoriented expression.
The times from inoculation to display of evident neuro-
logical signs suggestive of a prion disease (definite signs of
a TSE, usually ataxia and dullness or nervousness) ranged
from 18 to 54 months in both groups (mean and standard
error of mean [SEM] 27.2 m and 3.6 m in the pre-1975
group and 30.1 m and 4.6 m in the post-1990 group,
respectively). The mean incubation periods in bothBMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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groups did not differ significantly (Mann-Whitney U test:
p = 0.6).
One control steer inoculated with saline solution devel-
oped boisterous behaviour that compromised staff safety
and was culled at 60 mpi. The behaviour was explained by
the finding of some remaining testicular tissue on gross
necropsy. Remaining control animals (four steers inocu-
lated with saline solution and all five steers inoculated
with TSE-free brain) are still alive and were clinically unre-
markable as at June 2006.
Histopathology and immunohistochemistry
Histopathological changes of a spongiform encephalopa-
thy were present in the brains of all animals in which clin-
ical neurological signs were observed.
The lesion profiles of both groups inoculated with scrapie
material and comparisons with corresponding data from
brains of cattle i.c. and naturally infected with BSE are
given in Figure 1. Both scrapie inocula appear to produce
a similar lesion profile in cattle with similar vacuolation
scores in most of the 17 neuroanatomical areas and only
minor differences (reduced vacuolation scores in vestibu-
lar nucleus complex, cochlear nucleus, caudate nucleus
and putamen in the pre-1975 group). The most significant
differences from natural and experimental (i.c.) BSE were
observed in areas 1, 2 and 7 (markedly decreased vacuola-
tion scores in the nucleus of the solitary tract, the spinal
tract nucleus of the trigeminal nerve and central grey mat-
ter). Cluster analysis separated the pre-1975 and post-
1990 group from natural and experimental BSE (Figure
2A).
By contrast the immunohistochemical examinations
revealed three distinct patterns based on the type of PrP
deposits seen in different neuroanatomical areas (Table
1). In brains from cattle challenged with the pre-1975
inoculum disease-specific accumulation was generally
present throughout the central nervous system (CNS) and
consisted of predominantly granular cytoplasmic PrP
accumulation in neuronal perikarya (Figure 3A, C) and
intra-glial deposits, although in one animal PrP accumu-
lation was absent in the rostral medulla and the cerebel-
lum. By contrast the post-1990 inoculum produced a
widespread disease-specific PrP accumulation that con-
sisted predominantly of particulate PrP accumulation in
the neuropil (Figure 3B, D), accompanied by granular
cytoplasmic PrP deposits. However, in two cases from the
post-1990 group (PG 152/02 and 512/02), the pattern
more closely resembled that of the pre-1975 group with
the exception of cortical areas in which patterns similar to
that of the post-1990 group were seen.
Western blotting of PrPres
All diagnostic examinations of the saline inoculated steer
culled at 60 mpi were negative.
All clinically affected cattle inoculated with scrapie tested
positive for PrPres. However, the molecular profiles
obtained with the VLA hybrid WB technique differed
between the two groups, and none of the molecular pro-
Table 1: Immunolabelling pattern by brain area
Case No Group Clinical
presentation
Obex Rostral
medulla/
Cerebellum
Rostral
midbrain
Rostral
thalamus
Basal
ganglia/
frontal
cortex
Antibody
119/01 Pre 1975 Dull form 1 1 (Cerebellum negative) 1 1 1 486
609/01 Pre 1975 Dull form 1 1 1 1 1 486
743/01 Pre 1975 Dull form 1 1 1 1 1 145
749/01 Pre 1975 Dull form 1 Negative 1 1 1 145
959/01 Pre 1975 Dull form 1 1 1 1 1 145
1189/01 Pre 1975 Dull form 1 1 1 1 1 145
045/02 Pre 1975 Dull form 1 1 1 1 1 145
754/02 Pre 1975 Dull form 1 1 1 1 1 145
166/04 Pre 1975 Dull form 1 1 1 1 1 145
116/01 Post 1990 Dull form 2 2 3 3 3 486
920/01 Post 1990 Nervous form 2 2 3 3 3 145
1063/01 Post 1990 Dull form 2 2 3 3 3 145
152/02 Post 1990 Dull form 1 1 1 1+3 1+3 145
512/02 Post 1990 Nervous form 1 1 1 1 1+3 (Cortex negative) 145
1215/02 Post 1990 Dull form 2 2 3 3 3 145
96/04 Post 1990 Dull form 2 2 3 3 3 145
Group 1 – Predominantly neuronal with less neuropil labelling
Group 2 – Predominantly neuropil with less neuronal labelling (in both groups the overall distribution of IHC types is similar)
Group 3 – Like group 2 but with prominent aggregated/stellate formsBMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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files obtained were identical to the scrapie or BSE controls
(Figures 4 and 5). Immunoblotting of caudal medulla
from the eight pre-1975 challenged cattle gave a uniform
molecular profile for all animals in the group. Using mon-
oclonal antibody (mAb) 6H4, an unglycosylated band of
lower molecular mass than the natural scrapie control
sample was obtained and with mAb P4 there was no
immuno-reaction. This was similar to the corresponding
molecular profile obtained with these two mAbs for the
natural cattle BSE control sample. However, although the
molecular mass of the unglycosylated band was not signif-
icantly lower than that of the BSE control (approximately
0.2 kDa; p = 0.211) the monoglycosylated band (approx-
imately 0.3 kDa; p = 0.008) and the diglycosylated band
(approximately 0.5 kDa; p = 0.001) were significantly
lower.
In contrast, the molecular profiles obtained from the
seven cattle in the post-1990 group were more varied. The
caudal medulla tissue of five clinically affected cattle gave
a profile which had an unglycosylated band of higher
molecular mass than the natural scrapie sample (approxi-
mately 1.5 kDa; p = 0.001), and this was approximately
1.7 kDa higher than that obtained for the BSE control
sample. A marked immuno-reaction was obtained when
mAb P4 was used on the caudal medulla from these five
Lesion profiles in cattle challenged with scrapie and comparison with BSE cases Figure 1
Lesion profiles in cattle challenged with scrapie and comparison with BSE cases. 1. Nucleus of the solitary tract. 2. 
Nucleus of the spinal tract of the trigeminal nerve. 3. Hypoglossal nucleus. 4. Vestibular nuclear complex. 5. Cochlear nucleus. 
6. Cerebellar vermis. 7. Central grey matter. 8. Rostral colliculus. 9. Medial geniculate nucleus. 10. Hypothalamus. 11. Nucleus 
dorsomedialis thalami. 12. Nucleus ventralis lateralis thalami. 13. Frontal cortex. 14. Septal nuclei. 15. Caudate nucleus. 16. 
Putamen. 17. Claustrum.BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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cattle. Frontal cortex and brainstem regions were also
tested for one of these five cattle and the molecular profile
remained the same (results not shown).
The caudal medulla from the remaining two steers from
the post-1990 group (PG152/02 and PG512/02) gave a
similar result to the other five animals but the unglyco-
sylated protein band had a lower molecular mass. This
differed only slightly from the cattle BSE control sample
with the unglycosylated protein band approximately 0.5
kDa lower than that of the control. A sample of the brain-
stem, taken slightly more rostral to the obex, gave a WB
profile in steer PG512/02 that resembled the profile of the
other five steers (i.e. showing a higher molecular mass for
the unglycosylated band with mAb 6H4), whilst it
remained the same (i.e. lower molecular mass) in the
other steer (PG152/02) (Figure 6). However, the mAb P4
immuno-reaction in all seven cattle from the post 1990
group remained evident regardless of brain region. Mean
values for the unglycosylated, monoglycosylated and dig-
lycosylated molecular masses are shown in Table 2. The
means for the post-1990 samples were significantly higher
than those for both control samples (p < 0.001). The pre-
1975 sample means, with a single exception, were signifi-
cantly lower than both control means. The means for the
pre-1975 group of samples were significantly lower than
those for the post-1990 group (p < 0.001). The average
differences and their 95% confidence intervals are shown
in Table 3 (excluding the outliers in the post-1990 group).
The WB of the original pools (pre-1975 and post-1990)
gave a detectable molecular profile with mAb 6H4 only
for the post-1990 pool, which was similar to the ovine
scrapie control sample (Figure 7), whilst the molecular
profile with mAb P4 (clear immuno-reaction) was uni-
form for both inocula and similar to the ovine scrapie
control sample although the signal appeared stronger for
the post-1990 inoculum (Figure 8).
Tree diagram after cluster analysis of the vacuolation scores in selected neuroanatomical brain areas Figure 2
Tree diagram after cluster analysis of the vacuolation scores in selected neuroanatomical brain areas. A) Com-
parison of the profiles in cattle. B) Comparison of the profiles in mice. Natural BSE pool inoculum codes: study/inoculum.BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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The mean glycoform ratios obtained from individual
brain samples from cattle of the pre-1975 (n = 7) and
post-1990 (n = 6, included is the outlier PG152/02) group
were compared to those obtained from a natural BSE case
and a natural scrapie case (Figure 9). The results show that
the glycoform ratio for the BSE control field sample
(60.5:27.5) was separate from those obtained for the nat-
ural sheep scrapie control sample (45.2:36.8) and all
other samples from the two inoculated groups (ranging
between 52.7:34.3 and 38.0:39.3). The glycoform ratios
for caudal medulla and brainstem tissues from the out-
liers of the post-1990 group (PG152/05 and PG512/05)
were separate from the BSE control and were clustered
close to the ratio obtained for the sheep scrapie control
(Figure 10).
Mouse bioassay
Attack rate and incubation periods in mice inoculated
with the original scrapie pools and with brains from
scrapie-affected cattle are given in Table 4. Transmission
of the pre-1975 ovine scrapie brain inoculum into mice
was successful in RIII, C57Bl and VM mice whilst the post-
1990 inoculum did not transmit sufficiently into mice to
determine a lesion profile. When the brains from six
scrapie-affected cattle from the pre-1975 challenge group
were inoculated into mice, only three transmitted suffi-
Different PrPSc immunolabelling in the pre-1975 and post-1990 group Figure 3
Different PrPSc immunolabelling in the pre-1975 and post-1990 group. A) Olivary nucleus, pre-1975 pool. Immunola-
belling is predominantly intraneuronal – Group 1 type. B) Olivary nucleus, post-1990 pool. Immunolabelling is predominantly in 
the neuropil – Group 2 type. C) Caudate nucleus, pre-1975 pool. Immunolabelling is predominantly intracellular (intraneuronal 
and intraglial) – Group 1 type. D) Caudate nucleus, post-1990 pool. Immunolabelling is predominantly in the neuropil, with 
prominent stellate forms – Group 3 type.BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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ciently to RIII mice to determine a lesion profile. There
was also insufficient transmission in C57Bl or VM mice to
determine a lesion profile.
Brains from three scrapie-affected cattle from the post-
1990 group that were inoculated into mice transmitted to
RIII (from three steers), VM (from one steer) and C57Bl
mice (from one steer).
The lesion profiles in RIII mice and their comparison with
BSE are given in Figure 11. Similarities with respect to the
shape of the profiles are seen between the three cattle of
the pre-1975 group (peaks at grey matter areas 3, 5 and 7),
between the two cattle of the post-1990 group (peaks at
grey matter areas 5 and 7) and between the original pre-
1975 inoculum and the average BSE in mice (peaks at grey
matter areas 1, 4 and 7), although for BSE the average
lesion scores in the hypothalamus and lateral septal
nuclei were considerably lower (approximately half) com-
pared to the pre-1975 inoculum. Cluster analysis clearly
separated individual cattle of the pre-1975 or post-1990
group from the original pre-1975 inoculum and natural
BSE. The differences, expressed as Euclidian distances,
were much smaller between the different BSE pools than
between BSE and the pre-1975 inoculum (Figure 2B).
The lesion profiles of the pre-1975 inoculum and the
brains of two steers of the post-1990 inoculum, which
transmitted in VM mice and C57Bl mice respectively, did
not resemble those of BSE with peaks of vacuolation dis-
tributed in different grey matter areas when compared to
the BSE profile (data not shown).
Discussion
Inoculation of cattle with two pools of scrapie isolates,
sourced in GB before and during the BSE epidemic,
resulted in transmission of two main disease phenotypes,
one from each pool, as determined by neuropathological
and Western immunoblotting methods as well as biolog-
ical characterisation on transmission to mice. Neither of
the pools transmitted a disease identical to BSE.
Previous work [11,12,15] has demonstrated that cattle are
susceptible to scrapie by parenteral exposure routes and
succumb to a relatively uniform neurological disease that
is different to BSE in its clinical, histopathological and
Western immunoblot with monoclonal antibody 6H4 on caudal medulla samples from cattle in the pre-1975 and post-1990  group Figure 4
Western immunoblot with monoclonal antibody 6H4 on caudal medulla samples from cattle in the pre-1975 and post-1990 
group.BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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immunohistochemical features. These studies used
scrapie isolates from the USA and it was not known if the
disease was reproducible with scrapie isolates from GB.
Reported clinical signs in the recipient cattle were pre-
dominantly locomotor deficits resulting in difficulty ris-
ing and dullness or somnolence [11,12] whilst locomotor
deficits in BSE are generally accompanied by over-reactiv-
ity to external stimuli [16,17]. The clinical disease pro-
duced in this study by challenging cattle with the pre-
1975 inoculum resembled that described in the previous
studies, but two animals challenged with the post-1990
inoculum displayed progressive nervousness with tremor
and over-reactivity to external stimuli. These behavioural
and sensory changes are observed in BSE cases, both in
natural [16,17] and experimental [18,19] disease. As the
clinical presentation between different animals can be
quite variable despite similar widespread vacuolation or
PrPSc  accumulation in the brain, none of these neu-
ropathological markers may be directly responsible for
the observed clinical signs.
Differences between the pre-1975 and post-1990 group
were also observed neuropathologically: neuronal PrPSc
accumulation dominated in the pre-1975 group whilst
the post-1990 group showed predominantly neuropil
PrPSc accumulation, although the distribution of vacuolar
pathology in the brain was similar in both groups. Only
minimal vacuolar pathology was reported in two of the
USA studies [11,12] despite neuronal and neuropil PrPSc
accumulation [12], whereas in most clinical cases of BSE
neuropil vacuolation is prominent with the greatest vacu-
olar densities in the medulla, midbrain and thalamus
[5,6,20]. This prominence of neuropil vacuolation in the
hind brain is a feature in common with the brains of cattle
inoculated i.c. with the BSE agent (Figure 1), but in i.c.
inoculated cattle, and indeed, laboratory rodents similarly
inoculated, the fore brain areas have higher vacuolation
scores compared to natural exposures (Figure 1) or
peripheral routes of experimental exposure consistent
with the direct route of inoculation. That this difference
does not reflect divergence from the basic BSE profile is
supported by the cluster analysis, which linked naturally
Western immunoblot with monoclonal antibody P4 on caudal medulla samples from cattle in the pre-1975 and post-1990  group Figure 5
Western immunoblot with monoclonal antibody P4 on caudal medulla samples from cattle in the pre-1975 and post-1990 
group.BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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infected BSE cases with intracerebrally BSE infected cattle.
In contrast, in the scrapie-inoculated animals of both
groups there was relative sparing of the BSE target areas –
the nucleus of the solitary tract and the nucleus of the spi-
nal tract of the trigeminal nerve. A comparison of this area
in the two challenged groups, with cattle i.c. challenged
with BSE, and a small number (n = 9) of natural cases of
BSE revealed that involvement of the DNV is no greater in
the scrapie-challenged animals than in BSE (M.M. Sim-
mons, unpublished data).
Despite differences in the PrP accumulation between both
scrapie-challenged cattle groups, neither of the immu-
nolabelling patterns, or that reported in the USA study in
which IHC was performed [12] resembled that of BSE
[6,21,22]. The distinctive immunolabelled plaques
reported in two cases of the apparently novel, naturally
occurring bovine TSE in Italy [23] were not a feature of the
present or previous experimental transmissions of scrapie
to cattle.
WB examination of the original brain pools from scrapie-
affected sheep gave a molecular profile suggestive of ovine
scrapie with an obvious immuno-reaction with mAb P4.
The pre-1975 inoculum was not detected with mAb 6H4.
A similar finding is occasionally made in scrapie cases
with pre-clinical or early clinical disease where PrPres is
only detected by mAb P4 (M. Chaplin, unpublished data).
Both inocula comprised cerebral cortex of scrapie-affected
sheep, which is less ideal for the discriminatory WB than
brainstem [24]. The distribution of PrPSc or PrPres within
the brain of scrapie cases can vary significantly, with less
PrP accumulation in the cerebral cortices [25], which has
also been observed in clinical disease [26,27]. It is possi-
ble that disease-associated PrP was sparser in the cerebral
cortices of sheep in the pre-1975 pool, which is supported
by the weaker signal obtained with the P4 antibody com-
pared to the post-1990 pool. Irrespective of these findings,
they did not explain the different molecular profiles
obtained after transmission into cattle.
The molecular profile obtained from the pre-1975 chal-
lenged cattle did show similarities to results obtained pre-
viously for experimental BSE in sheep samples, and the
CH1641 sheep-passaged scrapie strain, although in both
of these a weak immuno-reaction occurs with the mAb P4
[10]. Therefore, the overall molecular profile for BSE from
cattle challenged with the pre-1975 scrapie pool was
markedly different to that obtained for natural scrapie
cases, and not identical to that obtained for experimental
BSE in sheep, CH1641, or bovine BSE cases. The molecu-
lar profile for the post-1990 group was dissimilar to that
obtained for cattle BSE, which gives no immuno-reaction
with the mAb P4 under the test conditions. The molecular
profiles obtained for the majority of the post 1990 group
were more akin to those obtained for natural scrapie, but
not identical, and were markedly different to those
obtained for experimental BSE in sheep, CH1641, or
bovine BSE cases.
The basis for discrimination by the WB test, using the two
different mAbs, is the location of the N-terminal cleavage
site for proteinase K digestion of PrPres between BSE and
scrapie. A study, using antibody blocking techniques and
Pepscan analysis, suggests that the N-terminal amino acid
sequence WGQGGSH remains intact only in sheep scrapie
digests and is detected by the mAb P4 while it is truncated
in sheep BSE and is therefore not detected by the same
antibody unless it is used at high concentrations [28]. It is
our experience that the P4 antibody gives only a weak
immuno-reaction for PrPres  from experimental BSE in
sheep samples and the sheep passaged scrapie strain
CH1641, and no immuno-reaction with PrPres  from
bovine BSE with this technique [10]. Interestingly, the
pre-1975 group of tissues showed more similarities to BSE
than the post-1990 group with regard to molecular pro-
Table 3: Mean differences (kDa) and the 95% confidence intervals 
between the pre-1975 group (n = 7) and the post-1990 group
 (n = 5)
Protein Band Mean difference 95% confidence interval
Unglycosylated 1.83 1.68 – 1.98
Monoglycosylated 1.91 1.74 – 2.08
Diglycosylated 1.31 1.11 – 1.52
Table 2: Comparison of the mean molecular masses (kDa) between the control samples and the two scrapie-inoculated groups
Group No. of samples 
(of n animals)
Unglycosylated Mean 
(SEM)
Monoglycosylated Mean 
(SEM)
Diglycosylated Mean 
(SEM)
BSE control 4 (n = 2) 18.6 (.12) 22.1 (.14) 26.3 (.16)
Scrapie control 4 (n = 2) 18.8 (.12) 22.2 (.14) 26.4 (.16)
Pre-1975 1 14 (n = 7) 18.4 (.05) 21.8 (.05) 25.8 (.06)
Post-1990 2 10 (n = 5) 20.3 (.06) 23.7 (.06) 27.1 (.08)
1 Not included are two animals with insufficient brain material for a comparative analysis.
2 Not included are the two animals that had a profile similar to the pre-1975 group.BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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files using the WB discriminatory criteria of immuno-reac-
tivity and molecular mass. However, the molecular
masses of the three PrPres bands were slightly, but repro-
ducibly, different between the pre-1975 group and the
BSE control (Table 2). The values for the monoglyco-
sylated and diglycosylated were significantly lower; there-
fore an exact match could not be established.
The higher molecular mass profile obtained in five of the
cattle in the post-1990 group (Figure 4 and Table 2) has
also been observed in brain tissue from Canada, sourced
from elk and white-tailed deer affected by chronic wasting
disease (CWD) and in a limited number of sheep from
Canada affected by scrapie [29,30]. The molecular mass
for the unglycosylated protein band obtained for the two
remaining animals from the post-1990 group was lower
than that obtained for the scrapie control sample, and the
other five steers in the group. This is more indicative of
BSE, but both animals gave marked immuno-reactions
with the mAb P4, which is more indicative of scrapie, so
again there was no exact match to scrapie or BSE from any
of the post-1990 group.
The different molecular profile obtained on a sample of
medulla rostral to the obex for PG512/02, which was the
same as that of the five other steers in the post-1990
group, is of particular interest. Samples from the caudal
medulla of scrapie-affected sheep in GB generally give a
uniform molecular mass profile, which is independent of
breed, geographic area and PrP genotype, with the WB
technique used in this study [24] but it could be hypothe-
sised that molecular mass variation in different brain
regions from the same animal may be due to a particular
strain or to a mixture of strains. Alternatively, differences
Western immunoblot with monoclonal antibody 6H4 on two different brain samples in outliers PG152/02 and PG512/02 Figure 6
Western immunoblot with monoclonal antibody 6H4 on two different brain samples in outliers PG152/02 and PG512/02.BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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in the degree of glycosylation of PrPres found in different
brain regions in mice have been attributed to different
degrees with which various cell types distributed through-
out the brain may glycosylate PrPres [31]. This has also
been hypothesised for ovine TSEs [32]. One study [29]
found that the PrPres glycoform pattern did not differ
when six different brain regions of clinically affected deer
or elk with CWD were analyzed. However, two types of
PrPres have been detected separately in some brain areas of
cases of sporadic Creutzfeldt-Jakob disease (CJD) [33-36],
which were associated with different immunohistochem-
ical features (diffuse PrPSc deposits or plaques) that may
result in different digestion properties with proteinase K
[36]. This is supported by the immunohistochemical pat-
tern in these two steers, which resembled that of the pre-
1975 group in most of the brain areas examined, although
a mixed pattern (resembling both the pre-1975 group and
the other steers in the post-1990 group) was observed in
more rostral brain sections. By contrast, variant CJD has
not shown any regional variation in PrP isotype or glyco-
sylation pattern when antibodies that detect both molec-
ular type 1 and type 2 were used, which is suggestive of
exposure to a single strain of agent [34]. Thus, the inocu-
lation of cattle with a pool of scrapie isolates of possibly
various strains may have contributed to the heterogeneity
in the molecular PrPres profiles observed in this study.
There was no evidence that the PrP genotype of the steers
was responsible for the phenotype diversity because the
disease produced in the two steers (PG920/01 and PG
959/01) that differed from the other steers with respect to
the octapeptide region was similar in the neuropatholog-
ical and molecular characteristics to that produced in
other steers in their group.
Electrophoretic molecular profiles of PrPres in BSE-affected
animals and humans with variant CJD have all demon-
strated a lower molecular mass for the unglycosylated pro-
tein band [10,37]. Thus, in this respect, experimental BSE
infections of mice [38,39] and experimental BSE in sheep
[10,28,40-42], are in contrast to most other TSEs in these
Western immunoblot with monoclonal antibody 6H4 on the original pre-1975 and post-1990 pools Figure 7
Western immunoblot with monoclonal antibody 6H4 on the original pre-1975 and post-1990 pools.BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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species. However, more recent studies in transgenic mice
expressing the human prion protein have shown that the
cattle BSE agent could propagate with either vCJD-like or
sporadic CJD-like properties [43]. Also, it has been shown
that even in vCJD and BSE two types of PrPSc can co-exist
[44]. Since there has been some more direct evidence of
possible different phenotypes of BSE. Two cases from Italy
have been described as having novel BSE molecular and
neuropathological characteristics [23]. Data from two BSE
cases in young animals (23 and 21 months) in Japan have
also been reported as giving different biochemical charac-
teristics to previous cases in Japan [45]. In France, another
different phenotype has also been described [46]. In this
last study a new phenotype was described, in three sam-
ples out of 58 French BSE cases tested, which exhibited a
higher molecular mass of unglycosylated PrPres and were
clearly reactive with mAb P4. As this was the predominant
molecular profile found for the post-1990 group in this
present study it could indicate that the scrapie pool used
for the inoculation of this group may have contained a
different strain, agent or particular cellularly located PrPSc
that was different to that in the pool used for the pre-1975
inoculations, and which manifested as a different pheno-
type in cattle, even though the original post-1990 pool
gave a uniform scrapie-like profile. The finding of signifi-
cantly different PrPres profiles for sporadic CJD and variant
CJD has led to speculation of an analogous spontaneous
rare sporadic form of BSE in cattle that might even have
been the origin of the BSE epidemic [37,41,47].
Previously, glycoform ratio analysis has been used to aid
in discrimination between experimental cases of BSE in
sheep and scrapie in sheep [8]. However, there is consid-
erable variation in signal when individual samples are
repeatedly measured, which leads to large standard error
measurements in the glycoform ratio analyses. In this pre-
vious research the glycoform ratios obtained for natural
scrapie cases and bovine BSE cases could not be distin-
Western immunoblot with monoclonal antibody P4 on the original pre-1975 and post-1990 pools Figure 8
Western immunoblot with monoclonal antibody P4 on the original pre-1975 and post-1990 pools.BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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guished whereas experimental BSE in sheep ratios were
distinct from natural sheep scrapie. In follow-up studies
on the reproducibility of the VLA hybrid test with regard
to molecular masses and glycoform ratio, the precision of
the technique was satisfactory for the molecular masses,
with coefficients of variation of less than 3%. This was not
the case for the glycoform measurements. When the signal
density for each single band was analysed repeatedly from
the same sample the coefficients of variation exceeded
10% and the variation for the glycoform ratio of the dig-
lycosylated band: monoglycosylated band was 26% (M.
Stack, unpublished data). Therefore, unless the differ-
ences are large it is clear that glycoform ratio analysis is a
less useful tool for discriminating between bovine BSE
and scrapie. However, in this study the glycoform ratios of
all samples, regardless of the inoculum or molecular
weight profile, were clustered around the ratio obtained
for the natural sheep scrapie control and separate from the
ratio obtained for the BSE field case (Figures 9 and 10).
Our results suggest that different forms of scrapie can
affect cattle and that resultant prion diseases in cattle may
have different manifestations, which might not be recog-
nised as readily as typical BSE when transmitted to other
species such as sheep. These possibilities increase the
importance of further investigation into pathological and
biochemical profiling for TSEs in ruminant species and in
fact a study is now underway in the UK which will exam-
ine tissue from retrospective BSE cases for possible signs of
phenotype variation not detected by earlier diagnostic
methods.
Conventional strain typing assays confirmed the trans-
mission of a prion disease in recipient cattle. The mouse
lesion profiles obtained from the original inocula and
after passage through cattle were different for both groups,
which is not unexpected since there was most likely a mix-
ture of different scrapie strains in the pools. Nonetheless,
the profiles were unlike those obtained with BSE. The
original pre-1975 inoculum gave a lesion profile and
incubation period range in RIII mice with some similari-
ties to BSE although the lesion profile peaks were greater
than those for BSE (Figure 11). In addition, cluster analy-
sis revealed that different BSE pools shared more similar-
ities (measured as Euclidian distance) with each other
than with the original pre-1975 inoculum (Figure 2B).
Similar profiles in RIII mice have been obtained from
individual scrapie isolates sourced from the UK although
they subsequently differed from BSE on second passage in
mice (R. Green, unpublished data). In addition, the gen-
erally poor attack rate in RIII mice after inoculation of
brains of scrapie-affected cattle is unlike BSE. This is in
agreement with the US study where the brain from a clin-
ically affected cow infected with scrapie failed to transmit
Glycoform profiles for cattle of the pre-1975 and post-1990 group compared to scrapie and BSE Figure 9
Glycoform profiles for cattle of the pre-1975 and post-1990 group compared to scrapie and BSE. The glycoform 
profiles are given as the percentage signal (mean with standard error) of the diglycosylated protein band plotted against that of 
the monoglycosylated band. The outlier PG152/02 of the post-1990 group is included.BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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to two mouse strains, NIH Swiss-Webster and NZW/LacJ
[48]. Besides, the lesion profiles in the other two mouse
strains (VM and C57Bl) obtained after inoculation with
the original pre-1975 inoculum did not resemble BSE.
Parenteral challenges of cattle with BSE affected brain
homogenate have, in general, produced a higher attack
rate (100%) and shorter incubation periods [49] when
compared to the cattle challenges with scrapie material in
this study. Clearly, this is, in part, related to dose, both
with respect to amounts and titer of inocula as shown by
decreasing attack rate and decreasing incubation period
when cattle are i.c. inoculated with BSE brainstem using a
10-fold dilution range from 10-3 to 10-8 (Hawkins SAC,
Wells G, Austin A, Ryder S, Dawson M, Blamire I, Sim-
mons M: Comparative efficiencies of the bioassay of
BSE infectivity in cattle and mice. In Proceedings of the
Cambridge Healthtech Institute's 2nd International Trans-
missible Spongiform Encephalopathies Conference: 2–3
October 2000; Alexandra, Virginia, USA). Nevertheless,
the inocula were prepared from cerebral cortices of clini-
cally affected scrapie cases and would be expected to con-
tain a high concentration of infectious agent, albeit
slightly lower than in the brainstem [50]. This relatively
low transmissibility may suggest that scrapie strains have
to undergo some adaptation process, perhaps requiring
serial passage, to survive as pathogens in the cattle popu-
lation. The historical use of meat and bone meal would
have provided this large potential for passage through cat-
tle.
In addition, little is understood regarding host responses
to infection with a mixture of TSE strains of different path-
ogenicity. Molecular analysis has demonstrated that co-
infection of mice with a mouse-adapted scrapie and BSE
strain results in a scrapie-like molecular profile [38]. A
mixture of ovine brains affected by scrapie and BSE inoc-
ulated into RIII, C57Bl or VM mice resulted in a mouse
lesion profile unlike BSE on first passage [51] although
the BSE strain usually produces a shorter incubation
period and a higher attack rate in RIII mice than scrapie
isolates [52]. Thus, the natural infection of cattle with var-
ious scrapie strains, some of which might be more patho-
genic to cattle, may not produce a BSE-like disease on first
passage. The use of transgenic mouse rodent models may
further aid in the interpretation of strain characteristics of
isolates from this study.
This study does not support the hypothesis that BSE was
caused by the replication of a scrapie strain in cattle, but it
was based on the two scrapie pools, the individual sheep
agent strain content of which was not characterised (due
to insufficient material) and which may not have been
representative of the spectrum of scrapie strains that may
have existed in the GB sheep population. Also, the pres-
ence in the pools of a scrapie strain that may produce a
BSE-like disease when transmitted to cattle cannot be
excluded since strain characteristics may also change after
transmission to other species. Thus, further sub-passage of
brains from scrapie-affected cattle into cattle is desirable
to investigate the effects of passage on the stability of the
phenotypes defined on primary transmission. Second
passages of the scrapie agent in cattle in studies conducted
in the USA have demonstrated that the appearance and
topographical distribution of neurohistological changes
and/or the distribution of PrPSc was almost identical to
that produced by primary inoculation [13,14]. Interest-
ingly, the description of clinical signs resembled BSE in
Table 4: Attack rate and mean incubation periods in mouse strains after transmission of ovine scrapie and bovine scrapie
Mouse strains RIII C57Bl VM
AR IP, SEM AR IP, SEM AR IP, SEM
Pre-1975 group Pre-1975 pool 11/11 477, 9 17/17 562, 13 13/16 698, 17
PG119/01 3/4 898, 56 1/8 726 1/6 741
PG609/01 4/6 904, 21 0/20 0/20
PG743/01 7/14 866, 45 1/8 785 2/9 754, 90
PG959/01 5/13 801, 53 0/20 0/20
PG749/01 8/13 937, 36 0/20 1/15 585
PG1189/01 10/11 918, 14 6/19 769, 58 3/4 839, 8
Post-1990 group Post-1990 pool 3/12 614, 20 4/18 603, 48 1/2 797
PG116/01 7/16 587, 29 0/20 0/20
PG920/01 13/16 576, 27 7/18 643, 46 0/20
PG1063/01 0/20 1/14 728 5/8 776, 20
AR Attack rate (calculated as the proportion of mice that developed disease out of the total number of mice still alive at the first positive diagnosis)
IPMean incubation period [days]
SEM Standard error of mean [days]BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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one passage study [14]. The studies in the USA have pro-
duced a relatively uniform neurological disease in cattle
after inoculation with several different sources of pooled
scrapie-infected tissue. This differed from BSE in cattle
with respect to both clinical and histopathological charac-
terisation. The findings in this study do not suggest the
same degree of uniformity in the disease presentation pro-
duced by inoculation of two different pooled inocula.
Neither of these presentations are identical to BSE but
share some aspects of characterisation in common. While
the characterisation of the disease forms in the cattle did
not reflect an entirely uniform phenotype after inocula-
tion with the post-1990 pooled scrapie source, it is of
interest in relation to the phenomenon of selection of
agent strains from a mixture on transmission across a spe-
cies barrier [53], that the phenotype within the pre-1975
pooled scrapie recipients was uniform and that this phe-
notype also occurred within recipients of the post-1990
pooled scrapie source. Whether differences between the
phenotypes detected in the temporally separated scrapie
source pools is simply related to TSE agent strain diversity
within the sheep population, or has some epidemiologi-
cal significance in terms of changes in extant agent strains
over time, cannot be determined from the present study.
Conclusion
Cattle infected with sheep scrapie agents may develop a
disease that is different from BSE in its clinical, patholog-
ical and biochemical features and variable disease presen-
tations may exist. The process by which scrapie strains
might produce a BSE-like disease in cattle was not evident
from this primary transmission experiment. However, it is
diagnostically significant that despite differences in the
biochemical and immunohistochemical characteristics
within both scrapie-infected groups in this study, and
between the 'bovine scrapie' phenotypes and BSE, a prion
disease was nevertheless diagnosed by IHC and WB exam-
ination of brainstem samples, consistent with interna-
tionally approved prion disease diagnostic methods in
ruminant species.
Glycoform profiles for the two outliers of the post-1990 group compared to scrapie and BSE Figure 10
Glycoform profiles for the two outliers of the post-1990 group compared to scrapie and BSE. The glycoform pro-
files are given as the percentage signal (mean with standard error) of the diglycosylated protein band plotted against that of the 
monoglycosylated band. Outliers were PG152/05 and PG512/02, which gave a molecular mass profile with mAb 6H4 that was 
different from the other cattle in the post-1990 group.BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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Methods
All procedures involving animals were approved by the
Home Office under the Animals (Scientific Procedures)
Act 1986.
Inocula
Two pools of homogenised brain were prepared as
described previously [54] from frozen archived cerebral
cortex of sheep of several different breeds affected with
natural scrapie, which was confirmed by histopathologi-
cal examination of the brain. The first comprised material
from eleven sheep killed prior to 1975 (five Cheviot, four
Suffolk and two Shetland) and the second, material from
ten sheep killed after 1990 (six Cheviot, two Suffolk, one
Halfbred and one Herdwick). Each scrapie case contrib-
uted approximately 1 g of brain material to the pools. The
sourcing periods were chosen to reflect the situation in
GB, where the occurrence of BSE had been unlikely prior
to 1975 whilst the epidemic was well established by 1990
and still increasing over the next two years. Brain material
from ten sheep (five Cheviot, one Dorset, four Suffolk)
imported from New Zealand, which is free from scrapie,
was prepared similarly as a TSE free control inoculum.
Histopathological and immunohistochemical examina-
tions of the donor brains were negative for scrapie. A DNA
sequencing analysis using a cleaved amplified polymor-
phic sequences method [55] as well as species-specific real
time polymerase chain reaction analysis [56] confirmed
the sole presence of ovine DNA in the brain pools.
Inoculation of cattle
A total of thirty castrate male Friesian/Holstein calves
were acquired from farms in GB with no history of BSE,
no evidence of exposure to meat and bone meal and no
known cases of BSE when admitted to the study (April
1999 – March 2000). Prior to inoculation all calves
Average lesion profiles in RIII mice for each inoculum and comparison with BSE Figure 11
Average lesion profiles in RIII mice for each inoculum and comparison with BSE. G1 Dorsal medulla nuclei. G2 
Cerebellar cortex. G3 Superior colliculus. G4 Hypothalamus. G5 Central thalamus. G6 Hippocampus. G7 Lateral septal nuclei. 
G8 Cerebral cortex (at the level of the thalamus). G9 Cerebral cortex (at the level of the septal nuclei). W1 Cerebellar white 
matter. W2 Tegmentum. W3 Pyramidal tract.BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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received a neurological examination and were considered
free from any neurological disease. Two groups of ten
calves each received one of the pooled sheep scrapie inoc-
ula. At 4–6 months of age each calf was inoculated i.c.
with 1.0 ml of a 10 per cent homogenate in saline of one
of the scrapie brain pools. Two control groups of five age-
matched castrate male cattle were similarly inoculated,
one with brain from sheep free from TSE and one with
sterile physiological saline solution. The i.c. inoculation
method used a semi-stereotaxic technique, which ensured
anatomically reproducible deposition of inoculum [54].
To prevent possible cross-contamination of animal
groups, staff were required to wear protective clothing,
with one set dedicated per pen, and all facilities used to
examine the animals (corridor, crush) were decontami-
nated by exposure to 20% sodium hypochlorite solution
for at least one hour between use for different groups.
PrP genotype of the calves, with respect to the octapeptide
repeats, was determined as described previously [19]. Two
animals (PG920/01 in the post-1990 group and PG 959/
01 in the pre-1975 group) were heterozygote for six copies
of the octapeptide (6:5), the remaining animals were
homozygote (6:6).
Clinical assessments
Clinical assessments comprised weekly observations for
15 minutes per group of five cattle to detect BSE-like signs
or any other neurological abnormality and monthly to
quarterly neurological examinations depending on clini-
cal progression from 12 months after inoculation (for
detailed description of assessment methods refer to [54]).
In addition, cattle were observed on two occasions for 12
and 24 hours, respectively, to record signs of disease that
may not have been evident at weekly observations. This
was later replaced by Closed Circuit Television monitor-
ing. Observations made in daily diaries by animal hus-
bandry staff were also included to determine the clinical
status.
Postmortem investigations
Cattle that developed a progressive neurological disease
were euthanased with pentobarbital administered intrave-
nously. The brain was removed aseptically, an intact trans-
verse section of the medulla oblongata at the level of the
obex sampled into 10% formal saline and the remaining
brain tissue bisected sagitally. The larger part containing
the midline structures was also fixed in formal saline for
neuropathological examination and the contra-lateral
part frozen at -80°C. Fixed tissues were prepared for rou-
tine histopathological examination in haematoxylin and
eosin (HE) stained sections and for immunohistochemi-
cal examination labelled for PrPSc. Whilst the first three
cases were labelled with rabbit polyclonal antibody
RB486 [57], further cases were labelled with rat mono-
clonal antibody R145 [58]. Both antibodies are C-termi-
nal specific, raised against the same bovine peptide
sequence and are comparable qualitatively for the immu-
nohistochemical detection of PrPSc in scrapie and BSE
(M.M. Simmons, unpublished data). CNS regions exam-
ined comprised the medulla oblongata at the level of the
obex, the rostral medulla at the level of the cerebellar
peduncles, caudal and rostral midbrain, cerebellum, tha-
lamus, occipital, parietal and frontal cortices as well as
spinal cord segments C5, T1, T6, T12 and L5–6. As part of
the histopathological examination, seventeen neuroana-
tomical sites of the brain were scored, on a 0–4 scale, for
the severity of vacuolation in HE stained sections to deter-
mine a lesion profile [5]. Scoring was conducted without
knowledge of the inoculation status of each animal and
by the previously described method [5]. To maintain uni-
formity of observations with those of previous studies,
only operators trained by M.M. Simmons carried out the
scoring. The lesion profiles obtained were compared to
those of naturally infected BSE cases diagnosed between
1987 and 1989 [5] and to those of ten cattle i.c. infected
with BSE, which were derived from a separate study con-
ducted at VLA Weybridge (Hawkins SAC, Wells G, Austin
A, Ryder S, Dawson M, Blamire I, Simmons M: Compara-
tive efficiencies of the bioassay of BSE infectivity in cat-
tle and mice. In Proceedings of the Cambridge Healthtech
Institute's 2nd  International Transmissible Spongiform
Encephalopathies Conference: 2–3 October 2000; Alexan-
dra, Virginia, USA). Briefly, groups of male castrate calves
were each inoculated i.c. at approximately 4 months of
age with a single dilution of inoculum prepared from
pooled brainstems from BSE affected cattle using a ten
fold dilution range of 10-3 to 10-8. Cattle were monitored
clinically until they developed neurological signs consist-
ent with BSE when they were killed and the brain exam-
ined to confirm the morphological phenotype of BSE and
the presence of disease specific PrP by IHC. The lesion
profiles for comparison with scrapie in cattle were
obtained from brains of ten BSE-affected cattle selected
from the various inoculation groups (10-3 – three animals,
10-4 – two animals, 10-5 – one animal, 10-6 – two animals
and 10-7 – two animals). The average lesion profiles in cat-
tle were compared by cluster analysis of the average lesion
score in each neuroanatomical area and the results dis-
played as vertical hierarchical tree plots as described for
strain characterisation of ovine scrapie [52]. Similarities of
the profiles were measured as Euclidean distance (Statis-
tica 7.0 Statistical software, StatSoft Inc., USA).
For the immunohistochemical examination, the CNS
regions were assessed for the localisation (neuropil or
neuronal) and type (particulate, linear, stellate) of PrPSc
immunolabelling [6].BMC Veterinary Research 2006, 2:31 http://www.biomedcentral.com/1746-6148/2/31
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Frozen tissues from the caudal medulla were examined by
a WB technique developed at the Veterinary Laboratories
Agency (VLA) to allow the comparison of molecular pro-
files ('VLA hybrid technique', [8,10]). PrPres is detected by
WB techniques as three protein bands which relate to dig-
lycosylated, monoglycosylated and unglycosylated forms
of the abnormal protein [59]. Differences between the
molecular masses of the unglycosylated protein band of
PrPres in natural scrapie, cattle BSE, and experimental BSE
in sheep cases has been previously published for this tech-
nique [10]. Discrimination was also possible by parallel
testing using two specific mAbs. The first, mAb 6H4 (Pri-
onics AG, Schlieren, Switzerland) is a mouse IgG1 anti-
body raised to human PrP, and was shown to have affinity
to the linear epitope amino acid sequence 144–152 [60],
and this sequence is equivalent to the 155–163 amino
acid sequence of bovine PrP and the sheep PrP sequence
147–155 [61], and therefore detects PrPres in both cattle
and sheep [30]. The second, mAb P4 (Biopharm, Darm-
stadt, Germany), is raised to a peptide with amino acid
sequence of ovine PrP 89–104 and is more selective for
scrapie PrPres under our test conditions due to its affinity
to ovine epitope amino acid sequence 93WGQGGSH99
[28,62] which differs from the bovine sequence at one
position 101WGQGGTH107.
As there were cases with an immunoblotting profile that
differed from that of other cases in the same inoculation
group, a second sample of the brainstem taken slightly
rostral to the obex was also examined, but for the pur-
poses of this report these examinations were limited to
five cases of the pre-1975 group and three cases of the
post-1990 group to ensure that enough material was avail-
able from other animals for future use.
Positive control tissue for the WB was obtained through
normal routine submissions of ovine and bovine brain to
the VLA. The natural scrapie control sample was from a
Shetland/Cheviot cross bred sheep with a PrPARQ/ARQ gen-
otype. The bovine BSE sample was from a clinical suspect
case that was positive by statutory diagnostic methods
(histopathological examination of medulla (obex) with a
typical vacuolar distribution pattern and WB for PrPres
using the Prionics®-Check WESTERN). All samples except
the bovine BSE and ovine scrapie positive controls were
run in duplicate in adjacent lanes of the gels and the mean
values for the unglycosylated, monoglycosylated and dig-
lycosylated molecular masses were used in the statistical
analyses of the variance, followed by tests of pre-specified
contrasts among the group means.
The immunoblots were visualised by means of enhanced
chemiluminescence (CPD-Star, Tropix). The blots were
quantified (molecular mass measurements and relative
quantity of the signal for glycoform analysis) using Fluor
S Multimager computer analysis (Quantity One, software
Biorad UK Ltd). For these analyses the centre position of
each protein band is used as the reading point. For glyco-
form analysis the combined signals from the blots treated
with mAb 6H4 are defined as 100% and the contribution
of each band calculated as a percentage of the whole. The
ratio of the mean values of the high molecular mass gly-
coform (diglycosylated band) and the low molecular
mass glycoform (monoglycosylated band) are plotted as a
scattergraph. The percentage signal obtained from the
unglycosylated band (the lowest) is not used. The mean
value and standard errors were obtained from three dupli-
cate gels for samples from the inoculated groups, pre-
1975 and post-1990, and for the BSE and scrapie controls.
The discriminatory WB (VLA Hybrid technique) was
applied retrospectively to the original scrapie pools (brain
homogenate as 10-1 dilution) to allow comparison with
the blots obtained from scrapie-affected cattle.
Mouse bioassay
The original sheep scrapie brain pools and brainstems
from cattle that developed a prion disease (six from the
pre-1975 group, three from the post-1990 group) were
each inoculated into a standard panel of three isogenic
mouse strains (RIII, C57Bl/6J, VM) for biological strain
typing. Mouse groups consisted of twenty mice. Both
mouse strains RIII and C57Bl carry the 'a' allele of the PrP
gene, which results in a shorter incubation period, whilst
the VM strain carries the 'b' allele of the gene; the alleles
encode proteins that differ by two amino acids at codons
108 and 189 [63]. These mouse strains had been used
before at VLA to characterise BSE and scrapie isolates. The
methods of inoculation and lesion profiling have been
described previously [4]. Transmission was sufficient to
determine a lesion profile if at least five mouse brains
were affected by spongiform changes [64]. The average
lesion profiles in RIII mice for each inoculum were com-
pared by cluster analysis as described above. Ten different
brain pools (natural BSE pools 1901) from a total of 197
naturally infected BSE cases, which had been prepared for
a BSE pathogenesis study [19] and inoculated into RIII
mice (published previously [4]), were used for compari-
son of the scrapie inocula with BSE.
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